Zhongping Shi is a notable inventor based in West Windsor, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, he has made remarkable advancements in drug development and therapeutic methods.

Latest Patents

Among his latest patents, one focuses on crystalline forms of a PAR4 inhibitor. This invention relates to co-crystals of a specific compound, where the co-former molecule is either succinic acid or citric acid. The patent outlines processes for preparing the co-crystal, pharmaceutical compositions derived from it, and methods for using these co-crystals to treat or prevent thromboembolic disorders. Another significant patent involves sulfilimine and sulfoxide methods for producing festinavir. This process utilizes a starting compound along with sulfilimine and sulfoxide process steps to create the desired compound.

Career Highlights

Zhongping Shi is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to contribute to innovative solutions in healthcare and medicine.

Collaborations

Throughout his career, Zhongping has collaborated with esteemed colleagues, including David R Kronenthal and John T Hynes. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Zhongping Shi's innovative work and patents have significantly impacted the pharmaceutical field, showcasing his dedication to advancing medical science. His contributions continue to pave the way for new therapeutic options and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.